DIRS.INFO The most relevant business & tech news

☆ Goldman says this pharma stock can rally nearly 70% thanks to key cancer treatment
▼ + stars: | 2024-11-21 | by ( Brian Evans | ) www.cnbc.com time to read: +1 min

Goldman Sachs sees big gains ahead for Merus on the back of the company's cancer treatment. The firm initiated coverage of the cancer therapeutics stock with a buy rating on Wednesday, alongside a $73 per share price target. Law said the antibody has already shown promising results and can be a key growth driver for the stock moving forward. MRUS YTD mountain Merus stock. Merus stock has advanced more than 56% already in 2024.

Persons: Goldman Sachs, Richard Law, Law, peto Organizations: Merus

☆ 'Mag 7' leads reversal — plus, we're adding a new stock to our Bullpen watchlist
▼ + stars: | 2024-11-19 | by ( Jeff Marks | ) www.cnbc.com time to read: +5 min

Next, we are going outside our current holdings and adding drugmaker Bristol Myers Squibb to the Bullpen, our watchlist of stocks that could join the portfolio. New Jersey-based Bristol Myers is in the midst of a transition phase under the leadership of new CEO Chris Boerner. Companies reporting earnings before the open Wednesday include Club stock TJX Companies , along with Target , Williams-Sonoma , and ZIM Integrated . THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Robert F, Kennedy Jr, Kennedy, Donald Trump, Wall, Eli Lilly, Bristol Myers, Chris Boerner, Boerner, Karuna, we'll, Stanley Black, Decker, Jim Cramer's, Jim Organizations: CNBC, ., Club, Nvidia, Dow Jones, of Health, Human Services, Senate, Bristol Myers Squibb, Bristol, pharma, Karuna Therapeutics, FDA, JPMorgan, Keysight Technologies, TJX Companies, Target, Williams, ZIM, Jim Cramer's Charitable Locations: New Jersey, U.S, Sonoma

☆ Geopolitics are finally starting to play a role in stock market action
▼ + stars: | 2024-11-19 | by ( Bob Pisani | ) www.cnbc.com time to read: +3 min

The S & P 500 has been drifting lower for a week. Pity the Wall Street strategists Pity the poor Wall Street strategists who are now writing their 2025 outlooks. That is about 10% above the current S & P 500 level. What is the current average yearly return of the S & P 500? The S & P 500 is up 0.3% since the close on Election Day.

Persons: Donald Trump's, Brian Belski, Morgan Stanley, Mike Wilson, Goldman Sachs, David Kostin Organizations: Bulls, Street, BMO Capital, UBS, ISI, Trump Locations: Russia, Ukraine, Iran

☆ RFK Jr. is Trump's pick to lead HHS — here's what he could do with that power
▼ + stars: | 2024-11-19 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +13 min

Kennedy will likely have some influence over who the president-elect chooses for those roles, health policy experts said. Ultimately, Kennedy's influence over immunization policy could lead to an increase in diseases preventable by vaccines, several health policy experts told CNBC. Investors are already bracing for a crackdown on food policy, with shares of processed food companies, such as Pepsi and Coca-Cola , falling on Friday. Seigerman said "there is little precedent in recent history for HHS policy dictating or affecting FDA regulation or approval of drugs." In 2023, pharmaceutical companies spent nearly $3 billion on advertising for the 10 most promoted drugs.

Persons: Robert F, Kennedy Jr, Thomas Machowicz, Donald Trump, Kennedy, Trump, trifecta, Spokespeople, Brandon Guerrero, Christina House, Gostin, Josh Michaud, Lawrence Gostin, Michaud, he's, Genevieve Kanter, Kanter, Covid, Richard Frank, Frank, Evan Seigerman, Seigerman, Dave Latshaw, Latshaw, Drugmakers, Joe Biden's, Amy Campbell Organizations: Reuters, Department of Health, Human Services, Republican, HHS, Affordable, Food and Drug Administration, Centers for Disease Control, National Institutes of Health, Centers, Medicare, Services, CNBC, CVS, Los Angeles Times, Getty, Health Defense, NBC News, FDA, NPR, Georgetown University, CDC, Vaccines, Children, Kennedy, NIH, University of Southern, Brookings Schaeffer Initiative, Health, pharma, RFK, BMO Capital, Pepsi, Trump, University of Illinois Chicago School of Law Locations: Phoenix , Arizona, U.S, Compton, Huntington Park, Kennedy ., University of Southern California

☆ How RFK Jr's war on obesity in the age of Ozempic could shake up the booming weight-loss industry
▼ + stars: | 2024-11-19 | by ( Rebecca Torrence | Hilary Brueck | ) www.businessinsider.com time to read: +9 min

Robert F. Kennedy Jr.'s proposed appointment to lead the US Department of Health and Human Services could have big consequences for a booming weight-loss market. AdvertisementHis likely appointment comes at a pivotal moment for the weight-loss industry, as long-lasting shortages of drugs like Ozempic come to an end. When Farmbox launched in 2014 to deliver healthy food boxes and educate consumers about nutrition, "nobody wanted to invest in us," Tyrner-Dolce said. Doug Mills-Pool/Getty ImagesKennedy's crusade against Big Food could run up against Trump's pro-corporation agenda, though. AdvertisementWeight-loss companies could get more attention — at a costKennedy's focus on holistic chronic disease care, including obesity care, could see a renewed funding rush to the space.

Persons: Trump, Robert F, Kennedy Jr, Kennedy, he's, Obama, Ashley Tyrner, Dolce, Farmbox, FarmboxRx, Michelle Obama, SAUL LOEB, Kennedy's, Jeff Nobbs, Nobbs, Doug Mills, Elon Musk, Donald Trump Jr, podcaster Joe Polish, Brooke Boyarsky Pratt, There's, Knownwell Pratt, Pratt, John Stanford Organizations: Human Services, US Department of Health, National Institutes of Health, Food and Drug Administration, Trump, Big Pharma, Senate, Novo Nordisk, Centers, Medicare, Services, Getty, Street, Department of Health, US Department of Agriculture, Shack, Business, Big Food, Trump's, KFC, McDonald's, Fox, FDA, Moderna Locations: Pennsylvania, Washington

☆ BMO expects Trump to pick a more conventional FDA commissioner after RFK Jr.'s nomination
▼ + stars: | 2024-11-19 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailBMO expects Trump to pick a more conventional FDA commissioner after RFK Jr.'s nominationEvan David Seigerman, BMO, joins 'Fast Money' to talk what Trump appointments mean for the biotech and pharma sectors.

Persons: Evan David Seigerman, Trump Organizations: BMO, Trump, FDA, RFK Jr, pharma

☆ 2 health stocks are buys. They've been beaten up enough on Trump's RFK Jr. pick for HHS
▼ + stars: | 2024-11-18 | by ( Jeff Marks | ) www.cnbc.com time to read: +5 min

Following Monday's trade, Jim Cramer's Charitable Trust will own 550 shares of DHR, increasing its weighting to roughly 3.6% from 3.4%. Since the election, Danaher shares have fallen from $250 each to $230 while Eli Lilly shares have dropped from $806 to $720. LLY YTD mountain Eli Lilly YTD Eli Lilly shares fell from $903 to $846 after a disappointing third-quarter report where inventory destocking of its fast-selling GLP-1 medications caused the company to miss estimates and lower full-year guidance. But the possible appointment of RFK Jr. has created a whole host of uncertainty for Eli Lilly and the drug stocks at large. If you look out to 2026, Lilly shares are trading at roughly 24 times.

Persons: Jim Cramer's, Donald Trump, Robert F, Kennedy Jr, We're, Danaher, Eli Lilly, Bioprocessing, Eli Lilly's, Lilly, Jim Cramer, Jim Organizations: DHR, Care Sector Fund, Department of Health, Human Services, RFK Jr, National Institutes of Health, HHS, CNBC Locations: Danaher

Andrew Harnik | Getty ImagesPresident-elect Donald Trump's return to the White House is poised to have big impacts on consumer health care. CMS, in turn, administers the Affordable Care Act marketplace and the Children's Health Insurance Program (CHIP), among other endeavors. A spokesperson for Trump's transition team did not respond to a request from CNBC for comment about the President-elect's health policy plans. Still, it's a 'big' gamble to forgo health insurance Around 3.8 million people will lose their health insurance if the subsidies expire, the Congressional Budget Office estimates. Short-term health insurance plans offer coverage for limited amounts of time, and typically on fewer medical services than comprehensive coverage.

Persons: Donald Trump, Andrew Harnik, Donald Trump's, Michael Sparer, Sparer, Trump, Robert F, Kennedy Jr, Kennedy, who's, Mario Tama, Cynthia Cox, I'd, Cox, Sabrina Corlette, Georgetown University's, Corlette, Carolyn McClanahan, Larry Levitt, Levitt, enrollee, they're, Yasin Ozturk, Biden, It's, — Organizations: Base Andrews, Getty, Affordable, Trump, Republican, Columbia University, of Health Policy, Management, of Health, Human Services, Medicare, Services, CMS, Children's Health Insurance, Washington Post, The Washington Post, CNBC, Providence St, Mary Medical Center, Finance, American, ACA, Cox, Congressional, Office, Republicans, Center, Health, Georgetown, Georgetown University's McCourt School of Public, Planning Partners, Medicaid, Social Security, Maskot, of Columbia, U.S, Capitol, Washington , D.C, Anadolu Agency, GOP, Corlette, pharma, Centers Locations: Base Andrews , Maryland, U.S, Duluth, Apple Valley , California, Jacksonville , Florida, Washington ,

☆ The admitted and investigated drug use in some of Trump’s top picks
▼ + stars: | 2024-11-18 | by ( Zachary B. Wolf | ) edition.cnn.com time to read: +6 min

CNN —President-elect Donald Trump’s Cabinet picks are unique for many reasons. Kennedy brings his addiction worldview to prescription drugs such as those overseen by the Food and Drug Administration, which he would oversee if confirmed as HHS secretary. But Musk denied allegations of past drug use as reported in The Wall Street Journal early this year. Federal employees are barred from taking illegal drugs, and there are no reports to indicate that any of Trump’s Cabinet or other administration picks are using illegal drugs. CNN has reported that this year, Trump’s team is bypassing long and cumbersome FBI background checks for some of his Cabinet picks.

Persons: Donald Trump’s, Matt Gaetz, It’s, –, Gaetz, Robert F, Kennedy Jr, Kennedy, Kurt Andersen, ” Elon Musk, Matthew Perry, Joe Rogan’s, Musk, Larry Kudlow, Hunter, Hunter Biden, Trump, Fred, Theo Von’s “, ” Von, Von, Sackler, Xi Jinping, Biden, Joe Biden, Florida’s Organizations: CNN —, Drug Enforcement, Department of Health, Human Services, Harvard University, Food and Drug Administration, Fox News, “ Department, Government, NASA, SpaceX, Street, Trump, CNN, Biden White, of Justice, Supreme, Purdue Pharma, Republican Locations: Florida, South Dakota, China, Mexico

☆ 5 new weight-loss drugs to watch in the fight for the next Ozempic
▼ + stars: | 2024-11-16 | by ( ) www.businessinsider.com time to read: +8 min

"Forthcoming medications take the blockbuster GLP-1 medications and up the ante." Like semaglutide (the active ingredient in Ozempic and Wegovy), it works on GLP-1, a hormone that regulates blood sugar and appetite. CagriSema adds it to the already-popular drug semaglutide, which itself helps manage hunger and blood sugar levels. "Longer-acting versions of GLP-1 medications offer the potential for greater convenience and potentially improved adherence and sustained use over time," McGowan said. Timeline: Data from Phase II trials is expected later this year, and planning is underway for Phase III trials.

Persons: Eli Lilly, Dr, Christopher McGowan, Eli Lilly's, Ozempic, retatrutide, VK2735, we've, they're, McGowan Organizations: Pharma, Novo Nordisk, Viking Therapeutics, Triple, Therapeutics, FDA, orforglipron, Nordisk, Reuters Locations: GLP, Mounjaro, California

☆ From 'brilliant' to 'dangerous': Mixed reactions roll in after Trump picks RFK Jr. for top health post
▼ + stars: | 2024-11-15 | by ( Https | Media-Cldnry.S-Nbcnews.Com Image Upload Newscms Frank-Thorp-Circle-Byline-Template.Jpg | Frank Thorp V | ) www.nbcnews.com time to read: +4 min

Thune ducked a question about whether he would support Kennedy's confirmation, saying that the process "is just getting started" and adding that there would be "a vetting process." Cassidy is currently the ranking member of the Senate Health, Education, Labor and Pensions committee and is considered a contender for chairing the committee in the next Congress. Sen. Ed Markey, D-Mass., said in a post to X that Kennedy was “Dangerous. I will hold any HHS Secretary to the same high standard of protecting and improving public health," Polis added in the later post. A majority of senators must vote in support of a nominee in order for the position to be confirmed.

Persons: WASHINGTON —, Donald Trump, Robert F, Kennedy Jr, Kennedy, Sen, John Thune, Thune, it’s, Bill Cassidy, Cassidy, Wisconsin Sen, Ron Johnson, Alabama Sen, Tommy Tuberville, Missouri Sen, Josh Hawley, Ron Wyden, Ed Markey, Chris Van Hollen, Patty Murray, Murray, Jared Polis, Polis Organizations: Department of Health, Human Services, Republican, Health, Education, Labor, Pensions, Wisconsin, Big Pharma, RFK, NBC News, Colorado Gov, HHS, FDA, NBC, Republicans, Senate Locations: WASHINGTON, Alabama, Missouri

☆ How Trump's selection of RFK Jr. as HHS secretary could impact the pharma sector
▼ + stars: | 2024-11-15 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailHow Trump's selection of RFK Jr. as HHS secretary could impact the pharma sectorJared Holz, healthcare sector strategist at Mizuho Securities America, and CNBC's Angelica Peebles join 'Power Lunch' discuss pharma stocks' reaction to Robert F. Kennedy Jr.'s appointment to lead the Department of Health and Human Services, what the incoming administration could mean for regulation in the sector, and more.

Persons: Jared Holz, Angelica Peebles, Robert F, Kennedy Jr Organizations: RFK Jr, pharma, Mizuho Securities America, Department of Health, Human Services

☆ Stocks making the biggest moves midday: Palantir, Moderna, Ulta Beauty, Alibaba and more
▼ + stars: | 2024-11-15 | by ( Pia Singh | In | ) www.cnbc.com time to read: +3 min

Global pharma stocks — Shares of several vaccine makers declined after President-elect Donald Trump selected prominent vaccine skeptic Robert F. Kennedy Jr. as health secretary on Thursday. Shares of Moderna and Pfizer slipped nearly 9% and 5%, respectively. Ulta slipped nearly 3% after Berkshire Hathaway revealed in a regulatory filing that it had sold around 97% of its shares, nearly dissolving its position in the beauty retailer. Berkshire had just bought the stock in the second quarter, making Ulta a relatively new bet. However, the company beat expectations on both lines in the fourth fiscal quarter and issued positive guidance for adjusted earnings per share.

Persons: Donald Trump, Robert F, Kennedy Jr, Eli Lilly, Warren Buffett, Berkshire Hathaway, Ulta, — CNBC's Sean Conlon, Alex Harring, Jesse Pound, Hakyung Kim, Lisa Han Organizations: Global pharma, Moderna, Pfizer, GSK, Novo Nordisk, Nasdaq, Securities and Exchange Commission, Super, New York Stock Exchange, Corp, Berkshire, Pool Corp, AST, Materials, LSEG Locations: China, Domino's, Berkshire

☆ RFK Jr.’s to-do list to make America ‘healthy’ — vaccines, fluoride and food — has health experts worried
▼ + stars: | 2024-11-15 | by ( Meg Tirrell | Katherine Dillinger | ) edition.cnn.com time to read: +12 min

“Donald Trump’s bungling of public health policy during the Covid pandemic cost hundreds of thousands of lives. “FDA’s war on public health is about to end,” he said in a social media post. Pack your bags.”That warning followed comments Kennedy has made about ending National Institutes of Health research into infectious diseases, putting doctors in the field on edge. water systems to remove fluoride from public water. Kennedy’s messaging on food policy has resonated with some health experts in that field.

Persons: Donald Trump’s, Robert F, Kennedy Jr, Dr, Ashish Jha, “, Carlos del Rio, Trump, ” Trump, “ Robert F, Kennedy, Jr, ” Robert Weissman, “ Donald Trump’s bungling, Michael Osterholm, ”, Osterholm, he’d, Ronald Reagan’s, he’s, ” Kennedy, Paul Offit, Jesse Watters, I’ve, Jason Schwartz, Edward Chen, it’s, I’m, Ashley Malin, ” Malin, Food Kennedy, Sanjay Gupta, Marion Nestle, Sen, Ron Johnson, Nestle, ” Nestle, CNN’s Carma Hassan, Nadia Kounang, Daniel Dale, Aaron Pellish Organizations: CNN, US Department of Health, Human, Brown University School of Public Health, Emory School of Medicine & Grady Health, Public Health, Health, HHS, Department of Health, Human Services, Public Citizen, Infectious Disease, University of Minnesota, US Centers for Disease Control, US Food and Drug, FDA, Pharma, of Health, Vaccine Education Center, Children’s Hospital of Philadelphia, CDC, Vaccines, Health Defense, Fox News, Yale School of Public Health, Trump White, U.S, American Dental Association, Environmental Protection Agency, MSNBC, Epidemiology, University of Florida’s College of Public Health, CNN Health Locations: Wisconsin

☆ I became CEO of a company that has helped millions of kids read—here's my no. 1 piece of career advice
▼ + stars: | 2024-11-15 | by ( Ernestine Siu | In Ernestinesiu | ) www.cnbc.com time to read: +9 min

Courtesy of Dr. Geetha Murali. Courtesy of Dr. Geetha Murali. "The human being, if given the basics... you are capable of so much more than you really think you are. Dr. Geetha Murali in Vietnam. Courtesy of Dr. Geetha Murali.

Persons: Geetha Murali, ” Murali, CNBC's, Read, Murali, —, Murali's, , wasn't, Michelle Obama, she's Organizations: UNESCO, CNBC, Indian Army, University of California, South Asian Studies, UC Berkeley Locations: New York, East, India, U.S, biostatistics, Berkeley, Vietnam

☆ How we're thinking about Eli Lilly after Trump picked obesity-drug critic RFK Jr. to run HHS
▼ + stars: | 2024-11-15 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +7 min

Shares of obesity drugmaker Eli Lilly fell more than 4% on Friday, extending a roughly 3% slide in Thursday's session. Ozempic is the posterchild of the fast-growing GLP-1 class, in which Novo Nordisk and Eli Lilly are currently the two dominant players. Bottom line Eli Lilly has been our favorite drug stock for years thanks to its stellar pipeline led by GLP-1s. But, at this point, Kennedy's nomination requires us to be more cautious on Eli Lilly in the near term. Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain.

Persons: Eli Lilly, Donald Trump, Robert F, Kennedy Jr, Kentucky Sen, Rand Paul, Kennedy, Trump, Eli Lilly's, John F, Kennedy —, LLY, Eli Lilly's GLP, Jim Cramer, David Ricks, Lilly, It's, Jim, it's, Jim Cramer's, Cristina Arias Organizations: Republican, Department of Health, Human Services, HHS, and Drug Administration, Centers for Disease Control, Medicare, Medicaid, Senate, Democratic, GOP, Media, Novo Nordisk, Moderna, Pfizer, Deutsche Bank, GSK, White, CDC, Street Journal, GLP, Big Pharma, FDA, tirzepatide, CNBC, Company, Pharmaceutical Locations: Washington, Kentucky, Danish, U.S, Alcobendas, Madrid, Spain

☆ Final Trade: West Pharma, Cameco, iShares Biotechnology ETF and Applied Digital Corp
▼ + stars: | 2024-11-15 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFinal Trade: West Pharma, Cameco, iShares Biotechnology ETF and Applied Digital CorpThe final trades of the day with the Fast Money traders.

Organizations: West Pharma, Cameco, iShares Biotechnology, Applied Digital Corp, Fast Money

☆ A tough week for stocks may soon force us to act. Here's where we would look to buy first
▼ + stars: | 2024-11-15 | by ( Jeff Marks | ) www.cnbc.com time to read: +6 min

Markets sink: Stocks are taking it on the chin Friday, capping off a week in which the S & P 500 fell about 2%. Bright spots : The two best-performing S & P 500 sectors this week are financials and energy. Health care was far and away the worst-performing group in the S & P 500. Next week: There's 11 companies in the S & P 500 reporting next week. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER .

Persons: Jim Cramer, There's, Donald Trump's, Jerome Powell, Trump, –, Morgan Stanley, Wells Fargo, Robert F, Kennedy Jr, Eli Lilly, we'll, Stanley Black, Decker, Jim Cramer's, Jim Organizations: CNBC, Traders, – BlackRock, Energy, Coterra Energy, Disney, Department of Health, Human Services, pharma, Nvidia, Walmart, Viking Holdings, TJX Companies, Palo Alto Networks, Target, Williams, Club, BJ's, Ross Stores, Baidu, PDD Holdings, GE Healthcare, Jim Cramer's Charitable Locations: Wells Fargo, Sonoma, Snowflake, Palo Alto

☆ Elon Musk is a showman, not an accountant
▼ + stars: | 2024-11-14 | by ( Allison Morrow | ) edition.cnn.com time to read: +6 min

The merch will be 🔥🔥🔥”If you need more evidence of how silly this whole thing is, note (as many commentators did online) that the efficiency department is being overseen by two people. On the campaign trail last month, Musk was asked how much he thought he could cut from the nation’s $6.5 trillion budget. Musk would be lucky to find $200 billion in the federal budget, former Treasury Secretary Larry Summers said at the Economic Club of New York on Tuesday. Even Trump joked to House Republicans on Wednesday that he can’t get rid of Musk, a source in the room told CNN. And that means Musk himself, as Tesla’s largest individual shareholder, is $55 billion richer today than he was a week ago.

Persons: Donald Trump, Elon Musk, ”, he’s, Vivek Ramaswamy, ” Trump, Elon, Vivek, Trump, Musk, ments on Organizations: New, New York CNN, bro, “ Department, Government, Ford, United Airlines, Republican Congress Locations: New York, le

☆ Cheat sheet: How RFK Jr., Trump's pick for HHS secretary, promises to 'Make America Healthy Again'
▼ + stars: | 2024-11-14 | by ( Hilary Brueck | ) www.businessinsider.com time to read: +9 min

Robert F. Kennedy Jr. is President-elect Trump's pick to lead the US Department of Health and Human Services. Advertisement"Make America Healthy Again" is the new healthcare slogan from Robert F. Kennedy Jr., President-elect Trump's new pick for Health and Human Services secretary. AdvertisementHere's what we know so far about Kennedy's public health philosophy, and what kinds of reforms he might fight for in 2025 and beyond. Kennedy's MAHA ideas include shifts in some basic public health protocolsMost Americans have fluoridated tap water. His stance has public health officials spooked, because part of what makes vaccination work so well is the fact that nearly everyone in our society does it.

Persons: Robert F, Kennedy Jr, Trump's, He's, he'll, —, Trump, Kennedy, Leonard Ortiz, I'm, Mandy Cohen, Lindsey Nicholson, Robert Califf, John F, Kennedy's, Bernie Sanders, it's Organizations: US Department of Health, Human Services, RFK, Service, Health, HHS, National Institutes of Health, for Disease Control, Prevention, Food and Drug Administration, MediaNews, Orange, Getty, NBC, Washington DC, Union, FDA, Pharma, Big Pharma Locations: Washington, California, Trump

☆ Lina Khan likely to be fired as FTC Chair under a Trump presidency
▼ + stars: | 2024-11-12 | by ( Allison Morrow | ) edition.cnn.com time to read: +5 min

Representatives for Trump’s transition team and the FTC didn’t respond to requests for comment. Wall Street, which has been on a tear since Trump’s decisive victory last week, appears to be ready to turn the page on the Khan era. Similarly, the FTC has gone after Big Tech, Big Pharma and even Big Mattress in the name of keeping competition robust. To them, Khan and her DOJ partner in trustbusting, Jonathan Kanter, represent a threat to the bottom line. Since last week’s election, both Kroger and Albertsons shares have risen sharply as investors anticipate the deal would face little resistance under Trump’s FTC.

Persons: CNN Business ’, New York CNN — Lina Khan’s, Donald Trump, Khan, she’s, Lina Khan, Jennifer Rie, kowtow, Jonathan Kanter, Elon Musk, Trump, ” Barry Diller, “, ‘, Republican “ Khanservative, JD Vance, Gail Slater, Vance, ”, David Kostin, Goldman Sachs, Kostin, Donald Trump’s, Brian Gardner, ” Gardner, Susie Wiles Organizations: CNN Business, New York CNN, Federal Trade Commission, FTC, Republican, Bloomberg Intelligence, CNN, Justice, Albertsons, Big Tech, Big Pharma, IAC, Democratic, Bloomberg, Kroger, Trump’s FTC, Goldman Sachs ’, White, Trump, Federal Reserve Locations: New York, it’s, trustbusting, Washington

☆ Trade Tracker: Jim Lebenthal buys more Abbvie
▼ + stars: | 2024-11-11 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailTrade Tracker: Jim Lebenthal buys more AbbvieJim Lebenthal, chief equity strategist at Cerity Partners, joins CNBC's 'Halftime Report' to discuss why he's buying more of the pharma stock on this dip.

Persons: Jim Lebenthal Organizations: Cerity Partners, pharma

☆ Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value
▼ + stars: | 2024-11-09 | by ( Kenneth Squire | ) www.cnbc.com time to read: +7 min

It invests in a concentrated portfolio of small and midcap life sciences companies, using activism as a tool to unlock value. A successful drug like Ohtuvayre would not just increase the life expectancies of patients with COPD, but it would lower costs for both health-care providers and COPD patients. Currently, there are over 8.6 million U.S. COPD patients with over 4 million remaining symptomatic despite treatment from the current commercial therapies. In early pooling analysis, Ohtuvayre showed a 41% reduction in exacerbations in COPD patients, almost double brensocatib. When Caligan announced its Verona position last month, the stock was trading at $33.40 per share or a $2.5 billion enterprise value.

Persons: Caligan, David Johnson, Ohtuvayre, Verona's, Verona, MorphoSys, bode, Ken Squire Organizations: Verona Pharma, Caligan Partners, Carlyle Group, FDA, MorphoSys AG, Novartis, pharma, 13D Locations: Verona, London, MorphoSys, Caligan's

☆ The sectors — and stocks — to buy in Asia after Trump's win, according to analysts
▼ + stars: | 2024-11-08 | by ( Amala Balakrishner | In Amala-Balakrishner | ) www.cnbc.com time to read: +3 min

Former U.S. President Donald Trump's victory over Vice President Kamala Harris in this week's election has raised questions about how Asia will be impacted. "When passed, the [tariffs] will sweep across Asia, particularly China [and] should spike volatility and compress multiples as uncertainty prevails." Even so, the analysts say the region is "more prepared than in 2016" and investment opportunities remain, especially given the weaker yen and stimulus in China. This will bring about "structural shifts in global supply chain ... [and] could boost infrastructure spending in ASEAN and South Asia," he added. The currency has fallen versus the dollar following Trump's win, hitting 154.7 per dollar on Wednesday — its weakest level since July 30.

Persons: Donald Trump's, Kamala Harris, India's, Hong, Tai Hui, Hui, Stocks, — CNBC's Lim Hui Jie Organizations: U.S, Trump, Macquarie Research, Nikkei, Dow Jones, Nasdaq, Morgan Asset Management, Congress, Mitsubishi Electric, Mitsubishi, Japanese pharma, Chugai Pharmaceutical, SK Hynix Locations: Asia, China, ASEAN, South Asia, U.S, Macquarie, Japan

☆ AstraZeneca shares fall on report of potential China probe fallout
▼ + stars: | 2024-11-05 | by ( ) www.cnbc.com time to read: +2 min

The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai, China, July 7, 2021. "As a matter of policy, we do not comment on speculative media reports including those related to ongoing investigations in China," AstraZeneca said. "If requested, we will fully cooperate with the Chinese authorities," the company added and said that its operations and delivery of medicines were ongoing in China. AstraZeneca is one of the biggest multinational drugmakers in China, which accounts for 13% of its overall revenue. In 2022, Chinese authorities had summoned AstraZeneca officials over an investigation of suspected medical insurance fraud by its employees, and had ordered that the drugmaker tighten its marketing activities.

Persons: Leon Wang, Wang, AstraZeneca Organizations: Astrazeneca, Artificial Intelligence, AstraZeneca, country's pharma Locations: Shanghai, China, Swedish

Search resuls for: "Adienne Pharma

25 mentions found